INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

DRIEHAUS CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000938206)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 369,617 Value ($000) $30,870 Avg Close — Range —
Q3 2024
Shares 349,418 Value ($000) $25,567 Avg Close — Range —
Q2 2024
Shares 215,439 Value ($000) $14,755 Avg Close — Range —
Q2 2022
Shares 514,956 Value ($000) $29,394 Avg Close — Range —
Q1 2022
Shares 488,460 Value ($000) $29,889 Avg Close — Range —
Q2 2021
Shares 272,140 Value ($000) $11,109 Avg Close — Range —
Q1 2021
Shares 216,955 Value ($000) $7,361 Avg Close — Range —
Q4 2020
Shares 163,518 Value ($000) $5,200 Avg Close — Range —
Q3 2020
Shares 99,644 Value ($000) $2,557 Avg Close — Range —
Q1 2017
Shares 17,964 Value ($000) $292 Avg Close — Range —
Q2 2016
Shares 93,536 Value ($000) $3,631 Avg Close — Range —
Q1 2016
Shares 91,796 Value ($000) $2,552 Avg Close — Range —
Q4 2015
Shares 103,147 Value ($000) $5,548 Avg Close — Range —
Q3 2015
Shares 88,561 Value ($000) $3,546 Avg Close — Range —